Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.


Abstract

Clobetasol propionate is a super-high potent class 1 topical corticosteroid available in several formulations, including a spray formulation that is approved for use up to 4 weeks in patients aged 18 years and older with moderate to severe plaque psoriasis.

The efficacy and safety of clobetasol propionate spray 0.05% has been extensively evaluated in clinical trials in more than 2200 patients with moderate to severe plaque psoriasis.

This article reviews the efficacy, safety, and tolerability of clobetasol propionate spray 0.05%. Clobetasol propionate spray 0.05% is a topical product with a documented efficacy and safety profile with good acceptability in patients with moderate to severe plaque psoriasis.


Full Text


    Subjects


    Similar articles

    Authors


    Publication date

    2012-04-05


    Journal

    Cutis; cutaneous medicine for the practitioner
    Cutis (0011-4162)

    Journal topics


    Language

    Eng.


    Copyright

    Cutis; cutaneous medicine for the practitioner

    Baylor Psoriasis Research Center, Baylor Research Institute, Baylor University Medical Center, 3900 Junius St, Ste 145, Dallas, TX 75246, USA. amderm [at] gmail.com


    Release reference

    Cutis. 2012 Feb;89(2):89-94



    Related books


    Español | English

    © Galenicom 1999-2013